ARTICLE | Company News
Retrophin jumps on Manchester deal
February 14, 2014 1:23 AM UTC
Retrophin Inc. (NASDAQ:RTRX) jumped $5.25 (49%) to $15.93 on Thursday after saying it will acquire fellow rare disease company Manchester Pharmaceuticals LLC (Fort Collins, Colo.) for $62.5 million, i...